Mass screening of newborn Swedish infants for alpha antitrypsin deficiency

Area of Science:

• Genetics
• Pediatrics
• Public Health

Background:

• Alpha1 antitrypsin deficiency (AATD) is a genetic disorder that can lead to lung and liver disease.
• Newborn screening is crucial for early detection and management of genetic conditions.
• Understanding the prevalence of specific AATD alleles is important for public health initiatives.

Purpose of the Study:

• To evaluate the reliability of a mass screening method for alpha1 antitrypsin deficiency in Swedish newborns.
• To determine the prevalence of the Pi Z phenotype and the frequency of the PiZ and Pi- alleles in the screened population.

Main Methods:

• A mass screening program was implemented for newborn infants in Sweden.
• A total of 108,000 infants were examined during the first year of the program.
• Screening criteria and methods were assessed for reliability in identifying AATD.

Main Results:

• The screening method and criteria for AATD were found to be reliable.
• The Pi Z phenotype occurred in 1 out of every 1,433 infants.
• The PiZ allele frequency was determined to be 0.026, with a Pi- allele frequency below 0.001.

Conclusions:

• The mass screening program for AATD in Swedish newborns is effective and reliable.
• The prevalence of the Pi Z phenotype and allele frequencies are established for this population.
• These findings support the implementation of newborn screening for AATD to enable early intervention.